ProCE Banner Activity

COVID-19 Antiviral Use in Patients With Renal Dysfunction

Clinical Thought
Patients with COVID-19 and renal dysfunction require special considerations when prescribing antiviral treatment. Read my take on how to assess risk vs benefit of COVID-19 antiviral use in these patients.

Released: October 21, 2022

Expiration: October 20, 2023

No longer available for credit.

Share

Faculty

Lynora Saxinger

Lynora Saxinger, MD, FRCPC, CTropMed

Cochair, Scientific Advisory Group
Alberta COVID-19 Emergency Coordination Centre
Associate Professor
Division of Infectious Diseases
Department of Medicine
University of Alberta
Edmonton, Alberta, Canada

Provided by

Provided by Clinical Care Options, LLC.
ProCE Banner

Supporters

Supported by an educational grant from

Gilead Sciences, Inc.

Faculty Disclosure

Primary Author

Lynora Saxinger, MD, FRCPC, CTropMed

Cochair, Scientific Advisory Group
Alberta COVID-19 Emergency Coordination Centre
Associate Professor
Division of Infectious Diseases
Department of Medicine
University of Alberta
Edmonton, Alberta, Canada

Lynora Saxinger, MD, has no relevant financial relationships to disclose.